OnKure Therapeutics, Inc.
For the period ended Jun 30, 2026. Filed Aug 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 4, 2026
OKUR$2.87+13.5%Stored close · as of Nov 6, 2026
Contents
Condensed Consolidated Financial Statements (Unaudited)
Item 1. Financial Statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.